103
Participants
Start Date
July 29, 2019
Primary Completion Date
August 15, 2023
Study Completion Date
May 15, 2026
Azacitidine
Azacitidine SC or IV will be administered at a standard dose of 75 mg/m\^2 on days 1-7 of each cycle.
Cusatuzumab
Cusatuzumab IV will be administered as 10 mg/kg or 20 mg/kg on days 3 and 17 of each cycle.
Hopitaux Universitaires de Geneve, Geneva
St Vincents Hospital Sydney, Darlinghurst
Westmead Hospital, Westmead
The Alfred Hospital, Melbourne
INSELSPITAL, Universitätsspital Bern, Bern
St Vincents Hospital Melbourne, Fitzroy
Kantonsspital Aarau, Aarau
Royal Perth Hospital, Perth
Ankara University Medical Faculty Hematology Department - Hematology, Ankara
Hosp. Univ. Son Espases, Palma
Hosp. Univ. Vall D Hebron, Barcelona
Institut Paoli Calmettes, Marseille
Hosp. Reina Sofia, Córdoba
Istituto Europeo di Oncologia, Milan
ASST Grande Ospedale Metropolitano Niguarda, Milan
Azienda Ospedaliera Spedali Civili di Brescia, Brescia
Hosp. Univ. Ramon Y Cajal, Madrid
Hosp. Univ. 12 de Octubre, Madrid
Hosp. Quiron Madrid Pozuelo, Pozuelo de Alarcón
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse
Rambam Medical Center, Haifa
Azienda Sanitaria Universitaria Integrata di Udine, Udine
Centre Hospitalier Universitaire (CHU) de Bordeaux Hopital HautLeveque Centre Francois Magendie, Pessac
Istanbul Egitim ve Arastirma Hastanesi, Istanbul
Dokuz Eylul Universitesi Tip Fakultesi, Izmir
CHRU Tours Hôpital Bretonneau, Tours
Hosp. Clinico Univ. de Salamanca, Salamanca
CHU Grenoble, Grenoble
Azienda Opedaliero-Universitaria Policlinico Sant'orsola Malpighi di Bologna, Bologna
Hosp. Univ. I Politecni La Fe, Valencia
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola
CHU d'Angers, Angers
Ondokuz Mayis Universitesi Tip Fakultesi, Samsun
Karadeniz Teknik University Medical Faculty, Trabzon
Tel Aviv Sourasky Medical Center, Tel Aviv
CHU Lyon Sud, Pierre-Bénite
Division of Hematology, Cardarelli Hospital, Napoli
S.P. Botkin Moscow City Clinical Hospital, Moscow
City Clinical Hospital # 40, Moscow
Komi Republic Oncology dispensary, Syktyvkar
St.-Petersburg Clinical Research Institute of Hematology and Transfusiology, Saint Petersburg
City clinical hospital #15, Saint Petersburg
Oncologic Dispensary No.2, Sochi
Ryazan Regional Clinical Hospital, Ryazan
Samara Region Clinical Hospital, Samara
Chelyabinck Regional Clinical Hospital, Chelyabinsk
Nizhniy Novgorod Region Clinical Hospital, Nizhny Novgorod
Ekaterinburg City Clinical Hospital # 7, Yekaterinburg
Hadassah Medical Center, Jerusalem
Universidade Estadual De Campinas, Campinas
Hospital das Clinicas de Porto Alegre, Porto Alegre
Hosp. de La Santa Creu I Sant Pau, Barcelona
Inst. Cat. Doncologia-H Duran I Reynals, Barcelona
UniversitaetsSpital Zuerich, Zurich
Gulhane Egitim ve Arastirma Hastanesi, Ankara
Dr.Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara
Lead Sponsor
Collaborators (1)
argenx
INDUSTRY
Janssen Research & Development, LLC
INDUSTRY
OncoVerity, Inc.
INDUSTRY